LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Mergers and Acquisitions AVROBIO has recently engaged in mergers and acquisitions activity, such as merging with Tectonic Therapeutic and selling assets to Novartis Pharma AG. These partnerships indicate potential opportunities for cross-selling gene therapy solutions to a wider customer base.

Former Executive Movement Key executives like Ostrowski and Petersen have departed AVROBIO, potentially creating openings to engage with their new employers, such as Akebia and Arbor, to introduce AVROBIO's innovative gene therapy offerings.

Market Recognition AVROBIO's recognition in the Corporate Activity and Growth category signifies industry acknowledgment of its innovative approaches. This recognition can be leveraged as a conversation starter with prospects looking for cutting-edge gene therapy solutions.

Competitive Landscape Analysis By assessing similar companies like CRISPR Therapeutics, Sarepta Therapeutics, and Editas Medicine, sales professionals can identify gaps in the market that AVROBIO's offerings can effectively address, creating sales opportunities in distinct niches.

Financial Health and Funding With reported revenue between $10M - 50M and funding of $60M, AVROBIO demonstrates financial stability and growth potential. This strong financial footing can enhance sales credibility and build confidence among potential clients seeking reliable gene therapy partners.

Similar companies to AVROBIO

AVROBIO Tech Stack

AVROBIO uses 8 technology products and services including 33Across, jQuery CDN, Modernizr, and more. Explore AVROBIO's tech stack below.

  • 33Across
    Advertising
  • jQuery CDN
    Content Delivery Network
  • Modernizr
    Javascript Libraries
  • Priority Hints
    Performance
  • X-XSS-Protection
    Security
  • Drupal Multisite
    Web Hosting
  • Draftpress HFCM
    Web Platform Extensions
  • Facebook
    Widgets

Media & News

AVROBIO's Email Address Formats

AVROBIO uses at least 1 format(s):
AVROBIO Email FormatsExamplePercentage
First.Last@avrobio.comJohn.Doe@avrobio.com
95%
FLast@avrobio.comJDoe@avrobio.com
2%
Last@avrobio.comDoe@avrobio.com
2%
First.L@avrobio.comJohn.D@avrobio.com
1%

Frequently Asked Questions

Where is AVROBIO's headquarters located?

Minus sign iconPlus sign icon
AVROBIO's main headquarters is located at 100 Technology Sq 6th Floor Cambridge, Massachusetts 02139 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is AVROBIO's phone number?

Minus sign iconPlus sign icon
You can contact AVROBIO's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AVROBIO's stock symbol?

Minus sign iconPlus sign icon
AVROBIO is a publicly traded company; the company's stock symbol is TECX.

What is AVROBIO's official website and social media links?

Minus sign iconPlus sign icon
AVROBIO's official website is avrobio.com and has social profiles on LinkedIn.

How much revenue does AVROBIO generate?

Minus sign iconPlus sign icon
As of June 2024, AVROBIO's annual revenue reached $15M.

What is AVROBIO's SIC code NAICS code?

Minus sign iconPlus sign icon
AVROBIO's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AVROBIO have currently?

Minus sign iconPlus sign icon
As of June 2024, AVROBIO has approximately 51 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Legal Officer: S. A.Chief Medical Officer: A. A.Chief Medical Officer: E. R.. Explore AVROBIO's employee directory with LeadIQ.

What industry does AVROBIO belong to?

Minus sign iconPlus sign icon
AVROBIO operates in the Biotechnology Research industry.

What technology does AVROBIO use?

Minus sign iconPlus sign icon
AVROBIO's tech stack includes 33AcrossjQuery CDNModernizrPriority HintsX-XSS-ProtectionDrupal MultisiteDraftpress HFCMFacebook.

What is AVROBIO's email format?

Minus sign iconPlus sign icon
AVROBIO's email format typically follows the pattern of . Find more AVROBIO email formats with LeadIQ.

How much funding has AVROBIO raised to date?

Minus sign iconPlus sign icon
As of June 2024, AVROBIO has raised $60M in funding. The last funding round occurred on Feb 01, 2018 for $60M.
AVROBIO

AVROBIO

Biotechnology ResearchMassachusetts, United States51-200 Employees

Our vision is to bring personalized gene therapy to the world. We target the root cause of genetic disease by introducing a functional copy of the affected gene into patients’ own hematopoietic stem cells (HSCs), with the goal of durably expressing the therapeutic protein throughout the body, including the central nervous system. Our first-in-class pipeline includes clinical programs for Gaucher disease and Hunter syndrome, as well as a preclinical program for Pompe disease. Our proprietary plato® gene therapy platform is scalable for planned global commercialization. We are headquartered in Cambridge, Mass. For additional information, visit avrobio.com, and follow us on Twitter and LinkedIn.

Section iconCompany Overview

Headquarters
100 Technology Sq 6th Floor Cambridge, Massachusetts 02139 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
TECX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $60M

    AVROBIO has raised a total of $60M of funding over 3 rounds. Their latest funding round was raised on Feb 01, 2018 in the amount of $60M.

  • $10M$50M

    AVROBIO's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $60M

    AVROBIO has raised a total of $60M of funding over 3 rounds. Their latest funding round was raised on Feb 01, 2018 in the amount of $60M.

  • $10M$50M

    AVROBIO's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.